
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Miconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Moksha8 Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
m8 Pharmaceuticals and Vectans Pharma Enter Agreement
Details : m8 Pharmaceuticals and Vectans Pharma have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc® (miconazole) for Mexico and Brazil.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 18, 2020
Lead Product(s) : Miconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Moksha8 Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
